Here’s a hot take for your coffee break: Simtra BioPharma just bought a massive plot in Indiana to ramp up production of injectable cancer meds. Translation? More of those cutting-edge, targeted treatments could be made closer to home, which might mean faster access for patients and maybe even lower costs down the line. Simtra’s aiming to be the first in the U.S. to make these next-gen cancer drugs at scale. Big moves for Midwest medicine! #Business #Industry #biotech